[Federal Register Volume 86, Number 226 (Monday, November 29, 2021)]
[Notices]
[Page 67725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25949]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-929]


Bulk Manufacturer of Controlled Substances Application: Pisgah 
Laboratories Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Pisgah Laboratories Inc. has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before January 28, 
2022. Such persons may also file a written request for a hearing on the 
application on or before January 28, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 30, 2021, Pisgah Laboratories Inc., 3222 Old 
Hendersonville Highway, Pisgah Forest, North Carolina 28768, applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Difenoxin..............................    9168  I
Methylphenidate........................    1724  II
Diphenoxylate..........................    9170  II
Levorphanol............................    9220  II
Remifentanil...........................    9739  II
Tapentadol.............................    9780  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. No other 
activities for these drug codes are authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-25949 Filed 11-26-21; 8:45 am]
BILLING CODE 4410-09-P